Newer Antipsychotic Drugs Raise Fatal Heart Attack Risk

Email this article to a friend

Printable Version

Articles Related to This Article: • Psychiatric Drugs: Chemical Warfare on Humans - interview with Robert Whitaker • The great direct-to-consumer prescription drug advertising con: how patients and doctors alike are easily influenced to demand dangerous drugs • The raw (and ugly) truth about the war on drugs NaturalNews Store Specials: • Revolutionary new Hurom Slow Juicer at the lowest price on the 'net + FREE shipping! • Certified Organic Nutiva Hemp Seeds at a huge discount (+ FREE bottle of hemp oil) • Omega-3 rich Chia Seeds at under $5 / lb. See more at the NN store...

(NaturalNews) The highly popular class of drugs known as atypical antipsychotics may significantly increase a patient's risk of suffering from a fatal heart attack, according to a new study conducted by researchers from the Vanderbilt University School of Medicine.

Antipsychotic drugs are designed to treat schizophrenia, but are often prescribed (sometimes off-label) for other conditions such as bipolar disorder, depression and even hyperactivity. The so-called atypical antipsychotics became popular in the 1990s and rapidly outstripped the older ("typical") antipsychotics in usage, largely due to the perception that they were safer. According to the current study, however, the newer drugs boost heart attack risk even more than the old ones.

"Many people thought the 'atypicals' would be much, much safer," researcher Wayne Ray said. "Our study suggests that they are not at all safer in regards to this serious end point."

The researchers reviewed medical records on 277,000 users of the Tennessee Medicaid program, looking at fatal heart attack risk among both users and nonusers of atypical antipsychotics.

Prior research has found that users of the older antipsychotics have a significantly higher risk of death than non-users, which led the FDA to update those drugs' warning labels in June.

"A similar increased risk was seen for current users of atypical antipsychotic drugs, who had a rate of sudden cardiac death that was more than twice that for non-users," the researchers in the current study wrote.

The researchers also found that the risk of fatal heart attack correlated directly with the dosage of antipsychotic being taken. The risk of heart death dropped quickly once patients stopped taking the drugs.

For years, the FDA has recognized that taking atypical antipsychotics significantly increases a person's risk of early death. This is attributed in part to the fact that the drugs interfere with the flow of potassium, an essential nutrient for regulating nerve and muscle (including heart) function.

Sources for this story include: uk.reuters.com.

Share

Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Psychiatric Drugs: Chemical Warfare on Humans - interview with Robert Whitaker • The great direct-to-consumer prescription drug advertising con: how patients and doctors alike are easily influenced to demand dangerous drugs • The raw (and ugly) truth about the war on drugs	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/025724_drugs_heart_attack_risk.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/025724_drugs_heart_attack_risk.html">Newer Antipsychotic Drugs Raise Fatal Heart Attack Risk</a>